Abstract
The Way2Drug informational-computational platform (www.way2drug.com/dr) provides access to the data on drugs approved for medicinal use in the USA and Russian Federation, as well as computational possibilities for the prediction of biological activity of drug-like organic compounds. Currently realized computational tools of the platform, which allow one to predict several thousands of biological activity types, including the interaction with molecular targets, pharmacotherapeutic and side effects, metabolism, acute toxicity for rats, cytotoxicity, influence on gene expression, and other properties characterizing the evaluation how promising are particular drug-like compounds as potential pharmaceuticals, are reviewed. Using the Way2Drug platform, one can not only select the most promising "hits" for the synthesis and testing of biological activity but also reveal new indications for the launched drugs.
Similar content being viewed by others
References
G. M. Barenboim, A. G. Malenkov, Biologicheski aktivnye veshchestva. Novye printsipy poiska [Biologically Active Substances. New Principles of Search], Nauka, Moscow, 1986, 363 pp. (in Russian).
Thomson Reuters Integrity URL, https://integrity.thomsonpharma.com.
G. R. Zimmermann, J. Lehár, C. T. Keith, Drug Discov. Today, 2007, 12,34.
R. M. Rydzewski, Real World Drug Discovery: A Chemist´s Guide to Biotech and Pharmaceutical Research, Elsevier, Oxford, 2008, 515 pp.
M. S. Kinch, A. Haynesworth, S. L. Kinch, D. Hoyer, Drug Discov. Today, 2014, 19, 1033.
Pharmaceutical Sciences: Breakthroughs in Research and Practice, IGI Global, Hershey, 2016, 1584 pp.
H. A. Gaspar, I. I. Baskin, G. Marcou, D. Horvath, A. Varnek, J. Chem. Inf. Model., 2015, 55,84.
I. V. Tetko, O. Engkvist, H. Chen, Future Med. Chem., 2016, 8, 1801.
Chemical Abstracts Services URL, http://www.cas.org.
PubMed URL, https://www.ncbi.nlm.nih.gov/pubmed.
U.S. Patent and Trade Office URL, https://www.uspto.gov/ patents-application-process/search-patents.
PubChem URL, https://pubchem.ncbi.nlm.nih.gov.
S. Kim, P. A. Thiessen, E. E. Bolton, J. Chen, G. Fu, A. Gindulyte, L. Han, J. He, S. He, B. A. Shoemaker, J. Wang, B. Yu, J. Zhang, S. H. Bryant, Nucleic Acids Res., 2016, 44, D1202.
ChEMBL URL, https://www.ebi.ac.uk/chembl.
G. Papadatos, A. Gaulton, A. Hersey, J. P. Overington, J. Comput. Aided. Mol. Des., 2015, 29,885.
ChEBI URL, https://www.ebi.ac.uk/chebi.
J. Hastings, P. de Matos, A. Dekker, M. Ennis, B. Harsha, N. Kale, V. Muthukrishnan, G. Owen, S. Turner, M. Williams, C. Steinbeck, Nucl. Acids Res., 2012, 41, D456.
DrugBank URL, https://www.drugbank.ca/.
D. S. Wishart, C. Knox, A. C. Guo, S. Shrivastava, M. Hassanali, P. Stothard, Z. Chang, J. Woolsey, Nucleic Acids Res., 2006, 34, D668.
SIDER URL, http://sideeffects.embl.de/.
M. Kuhn, I. Letunic, L. J. Jensen, P. Bork, Nucleic Acids Res., 2015, 44, D1075.
D. A. Filimonov, V. V. Poroikov, J. Comput.-Aided Mol. Design, 2005, 19,705.
S. Ekins, Computer Applications in Pharmaceutical Research and Development, John Wiley and Sons, Weinheim, 2006, 805 pp.
B. Goldakre, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, Straus and Giroux, Farrar, 2013, 448 pp.
V. M. Bezhentsev, D. S. Druzhilovskiy, S. M. Ivanov, D. A. Filimonov, G. N. Sastry, V. V. Poroikov, Pharm. Chem. J., 2017, 51,91.
V. Sh. Rubashkin, Predstavlenie i analiz smysla v intellektual´nykh informatsionnykh sistemakh [Representation and Analysis of the Sense in Intellectual Informational Systems], Nauka, Moscow, 1989, 190 pp. (in Russian).
V. K. Finn, Voprosy Filosofii [Problems of Philosophy], 2014, No. 2, 83 (in Russian).
I. V. Tetko, U. Maran, A. Tropsha, Mol. Inform., 2017, 36, 1600082.
H. Kubinyi, J. Braz. Chem. Soc., 2002, 13,717.
D. Stumpfe, Y. Hu, D. Dimova, J. Bajorath, J. Med. Chem., 2014, 57,18.
Y. Martin, J. I. Kofron, L. M. Traphagen, J. Med. Chem., 2002, 45, 4350.
K. Anusevicius, V. Mickevicius, M. Stasevych, V. Zvarych, O. Komarovska-Porokhnyavets, V. Novikov, O. Tarasova, T. Gloriozova, V. Poroikov, Res. Chem. Intermed., 2015, 41, 7517.
D. S. Druzhilovskiy, A. V. Rudik, D. A. Filimonov, A. A. Lagunin, T. A. Gloriozova, V. V. Poroikov, Russ. Chem. Bull., 2016, 65,384.
O. T. Devinyak, R. B. Lesyk, Curr. Comput. Aided Drug Des., 2016, 12,265.
D. A. Filimonov, V. V. Poroikov, E. I. Karaicheva, R. K. Kazaryan, A. P. Budunova, E. M. Mikhailovskii, A. V. Rudnitskikh, L. V. Goncharenko, Yu. V. Burov, Eksp. Klinich. Farmakol. [Experimental Clinical Pharmacology], 1995, 58, 56 (in Ruusian).
D. A. Filimonov, A. A. Lagunin, T. A. Gloriozova, A. V. Rudik, D. S. Druzhilovskiy, P. V. Pogodin, V. V. Poroikov, Chem. Heterocycl. Compds, 2014, 50,444.
L. Vegner, A. Peragovics, L. Tombor, B. Jelinek, P. Czobor, A. Bender, Z. Simon, A. Málnási-Csizmadia, J. Med. Chem., 2013, 56, 8377.
A. Lagunin, A. Stepanchikova, D. Filimonov, V. Poroikov, Bioinformatics, 2000, 16,747.
Yu. V. Burov, L. V. Korol´chenko, V. V. Poroikov, Byull. Vsesoyuzn. nauch. tsentra po bezopasnosti biologicheski aktivnykh veshchestv [Bulletin of the All-Union Scientific Center on Safety of Biologically Active Substances], 1990, No. 1, 4 (in Russian).
V. V. Poroikov, D. A. Filimonov, A. P. Budunova, NauchnoTekhn. Inform., Ser. 2 [Scientific Technical Information, Ser. 2], 1993, No. 6, 11 (in Russian).
V. V. Poroikov, in Meditsinskaya biofizika. Biologicheskie ispytaniya khimicheskikh soedinenii [Medical Biophysics. Biological Assays of Chemical Compounds], Meditsina, Moscow, 2005, 546 pp. (in Russian).
V. V. Poroikov, D. A. Filimonov, Yu. V. Borodina, A. A. Lagunin, A. Kos, J. Chem. Inform. Comput. Sci., 2000, 40, 1349.
A. V. Sadym, A. A. Lagunin, D. A. Filimonov, V. V. Poroikov, Pharm. Chem. J., 2002, 36,538.
A. Sadym, A. Lagunin, D. Filimonov, V. Poroikov, SAR and QSAR Environ. Res., 2003, 14,339.
A. Geronikaki, D. Druzhilovskiy, A. Zakharov, V. Poroikov, SAR and QSAR Environ. Res., 2008, 19,27.
D. S. Druzhilovskiy, A. V. Rudik, D. A. Filimonov, V. V. Poroikov, in Mater. IX Mezhdunar. Kongressa "Biotekhnologiya: sostoyanie i perspektivy razvitiya" [Proc. IX Intern. Congress "Biotechnology: State and Prospects of Development"], OOO RED GRUPP, Moscow, 2017, Vol. 1, p. 367 (in Russian).
A. Ariffin, N. A. Rahman, W. A. Yehye, A. A. Alhadi, F. A. Kadir, Eur. J. Med. Chem., 2014, 87,564.
H. Patel, Y. Sonawane, R. Jagtap, K. Dhangar, N. Thapliyal, S. Surana, M. Noolvi, M. S. Shaikh, R. A. Rane, R. Karpoormath, Bioorg. Med. Chem. Lett., 2015, 25, 1938.
T. G. Tolstikova, E. A. Morozova, S. V. Sysolyatin, A. I. Kalashnikov, Yu. I. Zhukova, V. N. Surmachev, Khimiya v Interesakh Ustoichivogo Razvitiya [Chemistry in Interests of Stable Development], 2010, No. 18, 511 (in Russian).
RF Patent No. 2558148; Byul. Izobret. [Invention Bulletin], 2015, 21 (in Russian).
RF Patent No. 2565766; Byul. Izobret. [Invention Bulletin], 2015, 29 (in Russian).
Way2Drug URL, http://way2drug.com.
D. A. Filimonov, A. V. Zakharov, A. A. Lagunin, V. V. Poroikov, SAR and QSAR Environ. Res., 2009, 20,679.
A. Lagunin, A. Zakharov, D. Filimonov, V. Poroikov, Mol. Inform., 2011, 30,241.
A. V. Zakharov, A. A. Lagunin, D. A. Filimonov, V. V. Poroikov, Chem. Res. Toxicol., 2012, 25, 2378.
GUSAR EnvironTox URL, http://www.way2drug.com/ gusar/environmental.html.
V. V. Goncharuk, A. L. Buben, O. A. Borisenok, V. I. Kozlovskii, I. M. Pun´ko, V. P. Vdovichenko, K. D. Praliev, Eksp. Klinich. Farmakol. [Experimental Clinical Pharmacology], 2016, 79, 7 (in Russian).
S. H. Unnissa, D. Rajan, J. Chem. Pharm. Res., 2016, 8,999.
E. V. Fedorova, A. V. Buryakina, A. V. Zakharov, D. A. Filimonov, A. A. Lagunin, V. V. Poroikov, PLoS One, 2014, 9, e100386.
A. Lagunin, S. Ivanov, A. Rudik, D. Filimonov, V. Poroikov, Bioinformatics, 2013, 29, 2062.
DIGEP Pred URL, http://www.way2drug.com/ge/.
V. Konova, A. Lagunin, P. Pogodin, E. Kolotova, A. Shtil, V. Poroikov, SAR and QSAR Environ. Res., 2015, 26,595.
PASS CLC Pred URL, http://www.way2drug.com/ Cell-line/.
P. V. Pogodin, A. A. Lagunin, D. A. Filimonov, V. V. Poroikov, SAR & QSAR Environ. Res., 2015, 26,783.
KinScreen URL, http://www.way2drug.com/kinscreen.
M. Nand, P. Maiti, R. Pant, M. Kumari, S. Chandra, V. Pande, Bioinformation, 2016, 12,311.
A. Thomas, P. K. J. Prashob, N. Chandramohanakumar, Int. J. Pharmacogn. Phytochem. Res., 2016, 8, 1828.
A. V. Rudik, A. V. Dmitriev, A. A. Lagunin, D. A. Filimonov, V. V. Poroikov, J. Chem. Inform. Model., 2014, 54,498.
A. Rudik, A. Dmitriev, A. Lagunin, D. Filimonov, V. Poroikov, Bioinformatics, 2015, 31, 2046.
A. Rudik, A. Dmitriev, A. Lagunin, D. Filimonov, V. Poroikov, J. Cheminform., 2016, 8,68.
MetaTox URL, http://way2drug.com/mg.
V. I. Dubovskaya, Ph. D. (Biol.) Thesis, Institute of Biomedical Chemistry, Moscow, 2017, 223 pp. (in Russian).
A. L. Hopkins, Nat. Chem. Biol., 2008, 4,82.
O. N. Koborova, D. A. Filimonov, A. V. Zakharov, A. A. Lagunin, S. M. Ivanov, A. Kel, V. V. Poroikov, SAR and QSAR Environ. Res., 2009, 20,755.
S. M. Ivanov, A. A. Lagunin, P. V. Pogodin, D. A. Filimonov, V. V. Poroikov, Toxicol. Sci., 2015, 145,321.
S. Ekins, A. J. Williams, M. D. Krasowski, J. S. Freundlich, Drug Discov. Today, 2011, 16,298.
J. Langedijk, A. K. Mantel-Teeuwisse, D. S. Slijkerman, M.-H. D. B. Schutjens, Drug Discov. Today, 2015, 20, 1027.
T. T. Ashburn, K. B. Thor, Nat. Rev. Drug Discov., 2004, 3,673.
D. Cavalla, Nat. Rev. Drug Discov., 2009, 8,849.
D. R. Flower, J. Pharmacovigilance, 2013, 1, 1000e103.
S. Naylor, J. M. Schonfeld, Drug Discov. World, 2014, 15,49.
D. Cavalla, Drug Discov. Today, 2013, 18,523.
C. L. Bellera, D. E. Balcazar, M. C. Vanrell, A. F. Casassa, P. H. Palestro, L. Gavernet, C. A. Labriola, J. Gálvez, L. E. Bruno-Blanch, P. S. Romano, C. Carrillo, A. Talevi, Eur. J. Med. Chem., 2015, 93,338.
T. I. Oprea, J. P. Overington, Drug Repurp., Resc. Reposit., 2015, 1,28.
S. A. Kryzhanovskii, R. M. Salimov, A. A. Lagunin, D. A. Filimonov, T. A. Gloriozova, V. V. Poroikov, Pharmaceut. Chem. J., 2012, 45,605.
Y. Gao, R. O´Caoimh, L. Healy, D. M. Kerins, J. Eustace, G. Guyatt, D. Sammon, D. W. Molloy, BMJ Open, 3, e002881.
FDA approved drugs URL, http://www.way2drug.com/dr/ int_fda_aprooved.php.
Farmatsevticheskie substantsii zaregistrirovannye v RF [Pharmaceutical Substances Registered in the Russian Federation] URL, http://www.way2drug.com/dr/russian_drug.php (in Russian).
D. Fourches, E. Muratov, A. Tropsha, J. Chem. Inf. Model., 2010, 50, 1189.
D. Fourches, E. Muratov, A. Tropsha, Nat. Chem. Biol., 2015, 11,535.
D. Fourches, E. Muratov, A. Tropsha, J. Chem. Inf. Model., 2016, 56, 1243.
Registr lekarstvennykh sredstv Rossii [List of Pharmaceuticals in Russia] URL, http://www.rlsnet.ru/ (in Russian).
A. Dalby, J. G. Nourse, W. D. Hounshell, A. K. I. Gushurst, D. L. Grier, B. A. Leland, J. Laufer, J. Chem. Inf. Comput. Sci., 1992, 32,244.
Perechen´ iz 96 prioritetnykh biomishenii dlya razrabotki lekarstv v Rossii [List of 96 Priority Biotargets for the Development of Drugs in Russia] URL, http://www.garant.ru/products/ipo/prime/doc/71320680/ (in Russian).
Pharma-2020 URL, http://pharma-2020.ru/ (in Russian).
J. G. Cumming, A. M. Davis, S. Muresan, M. Haeberlein, H. Chen, Nat. Rev. Drug Discov., 2013, 12,948.
A. Cherkasov, E. N. Muratov, D. Fourches, A. Varnek, I. I. Baskin, M. Cronin, J. Dearden, P. Gramatica, Y. C. Martin, R. Todeschini, V. Consonni, V. E. Kuz´min, R. Cramer, R. Benigni, C. Yang, J. Rathman, L. Terfloth, J. Gasteiger, A. Richard, A. Tropsha, J. Med. Chem., 2014, 57, 4977.
J. Gasteiger, Molecules, 2016, 21,151.
O. A. Tarasova, A. F. Urusova, D. A. Filimonov, M. C. Nicklaus, A. V. Zakharov, V. V. Poroikov, J. Chem. Inform. Model., 2015, 55, 1388.
SAR Creator URL, http://www.way2drug.com/dr/ substance.php.
ChemAxon URL, http://www.chemaxon.com.
D. Weininger, J. Chem. Inform. Comput. Sci., 1988, 28,31.
S. Heller, A. McNaught, S. Stein, D. Tchekhovskoi, I. Pletnev, J. Cheminform., 2012, 5,7.
MPDS URL, http://mpds.osdd.net/.
Author information
Authors and Affiliations
Corresponding author
Additional information
Based on the Materials of the XX Mendeleev Congress on General and Applied Chemistry (September 26—30, 2016, Ekaterinburg).
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 10, pp. 1832—1841, October, 2017.
Rights and permissions
About this article
Cite this article
Druzhilovskiy, D.S., Rudik, A.V., Filimonov, D.A. et al. Computational platform Way2Drug: from the prediction of biological activity to drug repurposing. Russ Chem Bull 66, 1832–1841 (2017). https://doi.org/10.1007/s11172-017-1954-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-017-1954-x